HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nutt, J. G. Articles by Woodward, W. R. Search for Related Content PubMed PubMed Citation Articles by Nutt, J. G. Articles by Woodward, W. R.

Does an inhibitory action of levodopa contribute to motor fluctuations?

Departments of Neurology (Drs. Nutt, Gancher, and Woodward), Pharmacology (Dr. Nutt), and Biochemistry (Dr. Woodward), Oregon Health Sciences University, Portland, OR.

The possibility that levodopa can both acutely improve as well as worsen motor function was investigated in eight fluctuating parkinsonian patients by administering 2-hour infusions of placebo and of levodopa at suprathreshold, threshold, and subthreshold rates when the subjects had been without medication overnight. Plasma levodopa and clinical status were monitored for an hour before, during, and for 3 hours after the infusions. Placebo infusions were associated with a mild deterioration in motor status during the period of monitoring. Subthreshold infusions were associated with greater motor deterioration than were placebo infusions in five of six subjects, but this deterioration did not occur in any specific temporal relation to the infusion. Threshold infusion rates in three subjects produced a transient improvement in motor function followed by deterioration to below the scores during the hour preceding the infusion and then returned to baseline. Suprathreshold rates in seven of the eight subjects were associated with motor improvement for ¹/₂ to 3¹/₂ hours followed by worsening to below baseline for 30 to 90 minutes and then spontaneous improvement to baseline function. These observations suggest that levodopa causes an acute deterioration in motor function following drug-induced improvement. Thus, the nadir of motor function in levodopa-treated patients may not be simply loss of dopaminergic stimulation and return to the untreated state, but may represent an inhibitory effect of levodopa.

Address correspondence and reprint requests to Dr. Nutt, Department of Neurology, Oregon Health Sciences University, 3181 SW Sam Jackson Park Road, Portland, OR 97201.

Supported in part by NINCDS 1 RO1 NS21062 and Clinical Centers Grant RR00334.

Received December 31, 1987. Accepted for publication in final form March 31, 1988.

This article has been cited by other articles:

				S. A. Gunzler, C. Koudelka, N. E. Carlson, M. Pavel, and J. G. Nutt Effect of Low Concentrations of Apomorphine on Parkinsonism in a Randomized, Placebo-Controlled, Crossover Study Arch Neurol, February 1, 2008; 65(2): 193 - 198. [Abstract] [Full Text] [PDF]

				P. Jenner The MPTP-treated primate as a model of motor complications in PD: Primate model of motor complications Neurology, September 23, 2003; 61(90063): S4 - 11. [Abstract] [Full Text]

				R. Wenzelburger, B.-R. Zhang, S. Pohle, S. Klebe, D. Lorenz, J. Herzog, H. Wilms, G. Deuschl, and P. Krack Force overflow and levodopa-induced dyskinesias in Parkinson's disease Brain, April 1, 2002; 125(4): 871 - 879. [Abstract] [Full Text] [PDF]

				A. M. Gordon and R. Reilmann Getting a grasp on research: does treatment taint testing of parkinsonian patients? Brain, August 1, 1999; 122(8): 1597 - 1598. [Full Text] [PDF]